PRJNA578260
Class1 HDAC inhibitor- mediated augmentation of incretin receptor agonism improves metabolic homeostasis
Combinatorial therapy of Class1 HDAC inhibitor and incretin receptor agonists improve glucose stimulated insulin secretion and correct diabesity.